RARA AND PML GENES IN ACUTE PROMYELOCYTIC LEUKEMIA

被引:28
|
作者
CHEN, Z [1 ]
CHEN, SJ [1 ]
机构
[1] SHANGHAI MED UNIV 2,SHANGHAI INST HEMATOL,MOLEC BIOL LAB,197 RUI JIN RD 2,SHANGHAI 200025,PEOPLES R CHINA
基金
上海市自然科学基金;
关键词
RETINOIC ACID RECEPTORS; RETINOIC ACID RECEPTOR-ALPHA; APL; PROMYELOCYTIC LEUKEMIA; ACUTE LEUKEMIA; RARA GENE; PML GENES; T(15; 17);
D O I
10.3109/10428199209051004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute promyelocytic leukamia (APL) is characterized by a specific chromosome translocation t(15;17). Recently, using molecular biology techniques, a number of laboratories have demonstrated that the gene coding for the retinoic acid receptor alpha (RARA), normally located on chromosome 17, is disrupted by the t(15;17) and fused with the PML gene on chromosome 15. The chromosome 17 breaks were mapped consistently within the second intron of the RARA gene while the chromosome 15 breaks were clustered in two limited regions within the PML gene. Molecular cloning and sequence analysis of the PML gene demonstrated a complex splicing pattern and this gene may encode a transcription factor. Different isoforms of the PML-RARA fusion transcripts were discovered which are produced as a result of distinct PML gene rearrangements. Sequence analysis of the reciprocal products of the translocation t(15;17) in some APL cases suggested the implication of topoisomerase II in mediating the DNA recombination. The RT/PCR procedure has been established to characterize the expression patterns of the PML-RARA fusion gene and to detect minimal residual disease (MRD). The biological activity of the PML-RARA fusion gene and its isoforms should be further explored.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 50 条
  • [31] Acute promyelocytic leukemia:: A novel PML/RARα fusion that generates a frameshift in the RARα transcript and ATRA resistance
    Zayed, Adham
    Couban, Stephen
    Hayne, Ormille
    Sparavalo, Nebojsa
    Shawwa, Allam
    Sadek, Irene
    Greer, Wenda
    LEUKEMIA & LYMPHOMA, 2007, 48 (03) : 489 - 496
  • [32] C-fms expression correlates with monocytic differentiation in PML-RARα+ acute promyelocytic leukemia
    Riccioni, R
    Saulle, E
    Militi, S
    Sposi, NM
    Gualtiero, M
    Mauro, N
    Mancini, M
    Diverio, D
    Lo Coco, F
    Peschle, C
    Testa, U
    LEUKEMIA, 2003, 17 (01) : 98 - 113
  • [33] C-fms expression correlates with monocytic differentiation in PML-RARα+ acute promyelocytic leukemia
    R Riccioni
    E Saulle
    S Militi
    N M Sposi
    M Gualtiero
    N Mauro
    M Mancini
    D Diverio
    F Lo Coco
    C Peschle
    U Testa
    Leukemia, 2003, 17 : 98 - 113
  • [34] THE SOLUTION STRUCTURE OF THE RING FINGER DOMAIN FROM THE ACUTE PROMYELOCYTIC LEUKEMIA PROTO-ONCOPROTEIN PML
    BORDEN, KLB
    BODDY, MN
    LALLY, J
    OREILLY, NJ
    MARTIN, S
    HOWE, K
    SOLOMON, E
    FREEMONT, PS
    EMBO JOURNAL, 1995, 14 (07): : 1532 - 1541
  • [35] Pro-proliferative function of the long isoform of PML-RARα involved in acute promyelocytic leukemia
    M I Tussié-Luna
    L Rozo
    A L Roy
    Oncogene, 2006, 25 : 3375 - 3386
  • [36] Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
    Zhu, J
    Koken, MHM
    Quignon, F
    ChelbiAlix, MK
    Degos, L
    Wang, ZY
    Chen, Z
    deThe, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3978 - 3983
  • [37] Pro-proliferative function of the long isoform of PML-RARα involved in acute promyelocytic leukemia
    Tussie-Luna, M. I.
    Rozo, L.
    Roy, A. L.
    ONCOGENE, 2006, 25 (24) : 3375 - 3386
  • [38] EPIDEMIOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA
    MELE, A
    STAZI, MA
    PULSONI, A
    VISANI, G
    MONARCA, B
    CASTELLI, G
    ROCCHI, L
    AVVISATI, G
    MANDELLI, F
    HAEMATOLOGICA, 1995, 80 (05) : 405 - 408
  • [39] Pediatric Acute Promyelocytic Leukemia
    Kutny, Matthew
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 : 19 - 20
  • [40] Acute Promyelocytic Leukemia: A Perspective
    Ravandi, Farhad
    Stone, Richard
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (09): : 543 - 544